The 2021 accounts came 25 days late. The other four were filed on time.
Checked score
Checked score
The higher the Checked score (0 to 100), the smaller the chance that the company goes bankrupt within twelve months. That chance sets the band, from Critical to Excellent, and within the band how the company does against its sector peers counts too. With a low score, agree a shorter payment term, an advance or security.
XXVisible after signing in
HiddenVisible after signing in
Bankruptcy probability within 12 months
Bankruptcy probability
It is the chance that the company goes bankrupt within twelve months, estimated from the registers, the annual accounts and the Belgian Official Gazette. At 0.2%, about 2 in 1,000 comparable companies go bankrupt. The higher it is, the shorter the payment term to agree.
XXVisible after signing in
Financial strength
Financial strength
Financial strength measures the balance sheet and the results with three figures out of 100 from the latest annual accounts: solvency, liquidity and profitability. It does not directly set the Checked score's band. How the company does against its sector peers on these and on growth does count for its place within the band.
XXVisible after signing in
XXVisible after signing in
XXVisible after signing in
Score breakdown
Visible after signing inVisible after signing in
Comparable companies, two years later
In July 2024, 26,977 companies had the same profile as Dr. Goevaerts MediMaP has now. Each dot stands for 68 companies, two years later.
94.9%
were still trading
3.5%
stopped another way
1.6%
went bankrupt
Micro
5 to 10 years old
solvency 30% or more
a profit of 5% of the balance sheet or more
Another 0.1% stopped without a precise date, possibly only after those two years.
Test of the method
The method was tested on the 497,965 companies of July 2024. Each company was given the bankruptcy share of the same profile a year earlier, in July 2023. The expectation was that 1.6% would go bankrupt within 24 months. In fact 1.7% went bankrupt.
The companies in ten equal groups, from the lowest to the highest expected share
Group
Expected
Actual
1
0.2%
0.2%
2
0.3%
0.5%
3
0.5%
0.6%
4
0.7%
0.8%
5
0.9%
0.9%
6
1.3%
1.5%
7
1.6%
1.8%
8
1.8%
1.8%
9
2.9%
3.1%
10
5.6%
6.1%
A company that went bankrupt had a higher expected share than one that kept going in 74.5% of comparisons. The level depends on the economy. In a year with more bankruptcies than the year before, the actual share is higher than the expected one.
This is an observation about 26,977 companies, not a prediction for Dr. Goevaerts MediMaP. The sector does not count, because the KBO no longer lists a sector for a company that has stopped. By sector, mostly the survivors would count, which would paint too rosy a picture.
Credit verdict
Credit verdict
The credit verdict says how much credit you can give the company on open account. “Acceptable” means normal terms, “With conditions” means limiting the amount or the term. “Not advised” means asking for payment up front.
Visible after signing inVisible after signing in
Credit check for an amount and term of your choice
Incorporation
Founding capital of €5,000 · Founded by Name after signing inVisible after signing in (founder and shareholder) · Name hiddenVisible after signing in appointed as director · published on 30-03-2021 · Gazette deed
“Het inrichten van algemene diensten en een medisch secretariaat in het bijzonder,die nuttig of…” (deed in Dutch)From the articles, 6 activities1 activities on the establishment units
Dr. Goevaerts MediMaP is a private limited company (BV).
When was Dr. Goevaerts MediMaP founded?
Dr. Goevaerts MediMaP was founded on 26-03-2021.
Is Dr. Goevaerts MediMaP still active?
Yes, Dr. Goevaerts MediMaP is an active enterprise in the KBO register.
What is the turnover of Dr. Goevaerts MediMaP?
The turnover in financial year 2025 is ≈ €390,000. This figure is estimated from the gross margin of €153,146 and 1,394 comparable companies of the same size. It probably lies between €240,000 and €740,000. It is a rough estimate.Financials
Is Dr. Goevaerts MediMaP profitable?
In financial year 2025, Dr. Goevaerts MediMaP made a profit of €104,706.
Where can I find the annual accounts of Dr. Goevaerts MediMaP?
Dr. Goevaerts MediMaP filed 5 annual accounts with the National Bank of Belgium, the latest for financial year 2025.
When are the next annual accounts of Dr. Goevaerts MediMaP due?
Dr. Goevaerts MediMaP must file the annual accounts for financial year 2026 by 31-07-2027.Timeline